Discontinuation report PRADAXA
| Report ID | 26385 |
| Drug Identification Number | 02358808 |
| Brand name | PRADAXA |
| Common or Proper name | Pradaxa Bottles 60's |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | DABIGATRAN ETEXILATE |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | Bottle of 60's |
| ATC code | B01AE |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-10-18 |
| Remaining supply date | 2017-10-18 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Pradaxa 150mg 6x10 Blister Pack format remains available |
| Company comments | Pradaxa 150mg 6x10 Blister Pack format remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-10-19 | French | Compare |
| v3 | 2017-10-19 | English | Compare |
| v2 | 2017-10-19 | French | Compare |
| v1 | 2017-10-19 | English | Compare |
Showing 1 to 4 of 4